Prolonged improvement of total pancreatic allograft function by previous intrathymic bone marrow cell injection in rats.
Donor-specific induction of tolerance was previously achieved in the diabetic rat by intrathymic injection of pancreatic islets. It allowed a secondary islet graft in any site without immunosuppression. Since total pancreatic graft in man is metabolically more proficient than islet graft, we attempted tolerance induction for total vascularized pancreas transplantation in diabetic BN recipient rats by an intrathymic bone marrow cell (BMC) injection from Lewis donor rats, associated to an antilymphocyte antibody (ALS) administration. Control groups consisted of isogenic grafts, allogenic grafts without tolerance induction and allogenic grafts with ALS alone. In all grafted groups, mean blood glucose and plasma insulin were normalised within 24 h. Graft rejection (clinically suggested by diabetes recurrence and later confirmed by histology) appeared at 18 +/- 2 postoperative days in the absence of intrathymic BMC injection and at 36 +/- 8 days in the group with BMC injection (p < 0.05). Intrathymic bone marrow graft was successful in delaying rejection in our study.
Drevillon
Catherine
C
Department of Surgery, George Pompidou Hospital, and University René Descartes, Paris 5, France.
Elian
N
N
Zinzindohoue
F
F
Carnot
Françoise
F
Bailbe
Danielle
D
Cugnenc
P-H
PH
Altman
J-J
JJ
D000818:Animals; D016026:Bone Marrow Transplantation / Q000379:methods; D003921:Diabetes Mellitus, Experimental / Q000601:surgery*; D006084:Graft Rejection / Q000473:pathology; D007267:Injections; D008297:Male; D010179:Pancreas / Q000473:pathology / Q000503:physiopathology*; D016035:Pancreas Transplantation; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D013950:Thymus Gland / Q000503:physiopathology*; D019172:Transplantation Conditioning; D023001:Transplantation Tolerance; D014184:Transplantation, Homologous